• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Zydus Cadila gets US FDA marketing approval for atazanavir capsules

    PHARMABIZ

    Mylan Pharms Generic Atazanavir; Cobicistat Receives Tentative Approval in US

    FDA

    EMA’s CHMP Recommends 6 New Meds, Releases Outcome of Sartan Investigation

    RAPS

    Teva Announces Exclusive Launch of a Generic Version of Reyataz in the US

    BIOSPACE

    Evotaz® (Atazanavir And Cobicistat): Gilead Sciences v. Mylan Pharmaceuticals

    PATENT LITIGATION

    Mylan S.A.S. Gets EU Nod For Atazanavir

    EMA

    Pharmacare`s Generic Atazanavir Receives Approval In US

    FDA

    EU approves BMS` once-daily HIV combo pill

    PHARMATIMES

    Government exempts AIDS drugs from customs duty

    THE ECONOMIC TIMES

    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    FIERCE PHARMA MFG

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.